We have demonstrated that MMP2 and -9–mediated SDC4 shedding is the underlying mechanism of endothelial glycocalyx damage in DKD and that this pathway is potentially amenable to therapeutic intervention. The gene discussed is MMP2; the disease is diabetic kidney disease.